Tsai, J. ., Navia, B. ., McElroy, S. ., Hudson, J. ., Grilo, C. ., Goldman, R. ., … Loebel, A. . (2020). 170 Efficacy and Safety of Dasotraline in Adults with Binge-Eating Disorder: A Randomized, Double-blind, Fixed-dose Trial. CNS Spectrums, 25(2), 308-309. https://doi.org/10.1017/S1092852920000863

Robertson, B. ., Wu, J. ., Fant, R. ., Schnoll, S. ., & McElroy, S. . (2020). Assessment of Amphetamine Withdrawal Symptoms of Lisdexamfetamine Dimesylate Treatment for Adults With Binge-Eating Disorder. The Primary Care Companion for CNS Disorders, 22(2). https://doi.org/10.4088/PCC.19m02540 (Original work published 2020)

Fleck, D. ., Eliassen, J. ., Guerdjikova, A. ., Mori, N. ., Williams, S. ., Blom, T. ., … McElroy, S. . (2019). Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder. Psychiatry Research. Neuroimaging, 286, 53-59. https://doi.org/10.1016/j.pscychresns.2019.03.003 (Original work published 2019)

Guerdjikova, A. ., Blom, T. ., Mori, N. ., Matthews, A. ., Cummings, T. ., Casuto, L. ., & McElroy, S. . (1969). Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review. Clinical Neuropharmacology, 42(6), 214-216. https://doi.org/10.1097/WNF.0000000000000367 (Original work published 1969)

Appolinario, J. ., Nardi, A. ., & McElroy, S. . (2019). Investigational drugs for the treatment of binge eating disorder (BED): an update. Expert Opinion on Investigational Drugs, 28(12), 1081-1094. https://doi.org/10.1080/13543784.2019.1692813

Yee, K. ., Serrano, D. ., Kando, J. ., & McElroy, S. . (2019). A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 28(12), 3385-3394. https://doi.org/10.1007/s11136-019-02277-8

Kalaria, S. ., McElroy, S. ., Gobburu, J. ., & Gopalakrishnan, M. . (2020). An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate. Clinical and Translational Science, 13(1), 88-97. https://doi.org/10.1111/cts.12682

Cuellar-Barboza, A. ., Winham, S. ., Biernacka, J. ., Frye, M. ., & McElroy, S. . (2019). Clinical phenotype and genetic risk factors for bipolar disorder with binge eating: an update. Expert Review of Neurotherapeutics, 19(9), 867-879. https://doi.org/10.1080/14737175.2019.1638764

Guerdjikova, A. ., Mori, N. ., Casuto, L. ., & McElroy, S. . (2019). Update on Binge Eating Disorder. The Medical Clinics of North America, 103(4), 669-680. https://doi.org/10.1016/j.mcna.2019.02.003

, McElroy, S. ., Geske, J. ., Winham, S. ., Gao, K. ., Reilly-Harrington, N. ., … Bobo, W. . (2018). The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.09.025 (Original work published 2018)